Loading...
Swasthya Healthcare Private Limited — Cytarabine Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #13 for Cytarabine · $65.4K export value · DGFT Verified
Swasthya Healthcare Private Limited is the #13 Indian exporter of Cytarabine with $65.4K in export value and 8 verified shipments. Swasthya Healthcare Private Limited holds a 0.6% market share in Cytarabine exports across 1 countries. The company exports 2 pharmaceutical products worth $121.3K across 2 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| NETHERLANDS | $1.4M | 164 | 19.0% |
| BRAZIL | $1.3M | 39 | 17.6% |
| UNITED KINGDOM | $542.4K | 60 | 7.1% |
| SOUTH AFRICA | $489.1K | 26 | 6.4% |
| PHILIPPINES | $475.0K | 50 | 6.2% |
| SPAIN | $464.2K | 27 | 6.1% |
| THAILAND | $408.0K | 21 | 5.4% |
| COLOMBIA | $406.6K | 30 | 5.3% |
| ITALY | $381.9K | 39 | 5.0% |
| RUSSIA | $341.1K | 17 | 4.5% |
India exports Cytarabine to 110 countries. The top destination is NETHERLANDS (19.0%), followed by BRAZIL and UNITED KINGDOM.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ALLOGA FRANCE | NETHERLANDS | $530.3K | 36 |
| ACCORD FARMACUTICA LTDA | BRAZIL | $460.3K | 13 |
| ACCORD UK | UNITED KINGDOM | $441.7K | 25 |
| BROCACEF NL : HUB | NETHERLANDS | $385.2K | 42 |
| ACCORD FARMACUTICA LTDA. | BRAZIL | $334.3K | 9 |
India exported $9.8M worth of Cytarabine through 1,825 shipments from 175 suppliers to 110 countries, serving 381 buyers globally. Swasthya Healthcare Private Limited contributes $65.4K to this total, accounting for 0.6% of India's Cytarabine exports.
Swasthya Healthcare Private Limited's average Cytarabine shipment value is $8.2K per consignment, based on 8 shipments totaling $65.4K.
Swasthya Healthcare Private Limited ranks #13 among 175 Indian Cytarabine exporters with a 0.6% market share. The top 3 exporters are INTAS PHARMACEUTICALS LIMITED ($5.1M), FRESENIUS KABI ONCOLOGY LIMITED ($1.8M), NAPROD LIFE SCIENCES PRIVATE LIMITED ($557.0K). Swasthya Healthcare Private Limited processed 8 shipments to 1 destination countries.
What Swasthya Healthcare Private Limited must comply with to export Cytarabine to its top destination countries
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | PLEASANT EXPORTS | $131.9K | 10 | 1 | $13.2K |
| 12 | MEDWISE OVERSEAS PRIVATE LIMITED | $70.4K | 3 | 2 | $23.5K |
| 13 | SWASTHYA HEALTHCARE PRIVATE LIMITED ★ | $65.4K | 8 | 1 | $8.2K |
| 14 | VHB MEDI SCIENCES LIMITED | $59.7K | 4 | 3 | $14.9K |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 249 | 13.6% |
| SAHAR AIR | 242 | 13.3% |
| DELHI AIR | 159 | 8.7% |
| AHEMDABAD AIR ACC (INAMD4) | 145 | 7.9% |
| DELHI AIR CARGO ACC (INDEL4) | 144 | 7.9% |
| AHEMDABAD AIR | 142 | 7.8% |
| MUNDRA SEA (INMUN1) | 139 | 7.6% |
| MUNDRA SEA | 111 | 6.1% |
Swasthya Healthcare Private Limited exports 2 products worth $121.3K. Beyond Cytarabine, top products include Vincristine. View the complete Swasthya Healthcare Private Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Cytarabine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Swasthya Healthcare Private Limited's Cytarabine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Swasthya Healthcare Private Limited
Full Company Profile →
2 products · $121.3K total trade · 2 categories
| M/S MANAS MED | RUSSIA | $302.6K | 15 |
| MULTICARE PHARMACEUTICALS PHILIPPIN | PHILIPPINES | $291.6K | 25 |
| FRESENIUS KABI MALAYSIA SDN BHD | MALAYSIA | $276.4K | 8 |
| ACCORD HEALTHCARE ITALIA SRL | ITALY | $257.6K | 22 |
| ACCORD FARMACUTICA LIMITEDA | BRAZIL | $256.8K | 7 |
India's Cytarabine is purchased by 381 buyers worldwide. The top buyer is ALLOGA FRANCE (NETHERLANDS), followed by ACCORD FARMACUTICA LTDA and ACCORD UK.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Swasthya Healthcare Private Limited ranks #13 among 175 Indian Cytarabine exporters. Average shipment value of $8.2K compared to the market average of $56.0K. The closest competitors by value are PLEASANT EXPORTS and MEDWISE OVERSEAS PRIVATE LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 110+ countries, 381+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Swasthya Healthcare Private Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cytarabine. For current shipment-level data, contact TransData Nexus.